ATM and gastric cancer: Considering the novelty of this study, while TP53, ATM, and RAD51 have been individually implicated in radiotherapy resistance, our study presents a novel integrative approach by identifying and functionally validating the combined regulatory impact of TP53, RAD51, and BAX in gastric cancer, with supporting evidence for ATM’s epigenetic suppression.